In a move warmly welcomed by parents and paediatric rheumatologists alike, the Pharmaceutical Benefits Scheme

JAFA welcomes the Health Minister’s April 27, 2022 announcement of the largest-ever research funding allocation

This ground-breaking Inquiry was instigated by JAFA and conducted by the House of Representatives Standing

Victoria Allen, the inaugural Chair of Juvenile Arthritis Foundation Australia (JAFA) will retire from the

March 8, 2022 saw an historic landmark for Juvenile Arthritis /childhood rheumatic diseases (JA/CRDs) in

Since it’s inception JAFA with many parents, grandparents and friends, have actively been advocating the

JAFA has long been concerned about the social isolation experiences by children with JA that

The past two years of JAFA’s existence has heralded truly significant milestones for children and

JAFA worked hard throughout 2021 advocating to bring about this much-needed nation-wide inquiry and was

The Juvenile Arthritis Foundation Australia (JAFA) is delighted to announce that it has been named